Edwards Lifesciences (NYSE:EW) is now in the hunt for a new CFO. The company announced that the existing officeholder, Thomas Abate, is to retire later this year. The 59-year-old will step down once his successor is in place.

Edwards has retained an executive search firm to assist in the process of finding a new CFO.

Abate has been Edwards' finance chief since January 2006. Before that, he served as the company's vice president and controller following its spinoff as an independent entity -- it previously belonged to Baxter International. In the years before the spinoff, Abate worked in several "finance-related positions" at Baxter.

Fool contributor Eric Volkman and The Motley Fool have no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.